Riomet Articles
Merck & Co rises 2.3% as it beats 4th quarter 2009 sales forecast, boosted by Schering-Plough
17 February 2010
AstraZeneca sees strong earnings and revenue growth in2009 but a slowdown in 4th qtr
28 January 2010
Merck & Co signs performance-based contract with CIGNA
24 April 2009
Merck & Co 1st-qtr profit slumps 57%
21 April 2009
PrandoiMet launched in USA
16 February 2009
EMEA's PDCO thumbs-up to eight PIPs
3 November 2008
Santarus starts promotion of Glumetza
20 October 2008
List of new CHMP drug recommendations
6 October 2008
Merck Serono's Glucophage sachet gets nod from CHMP
15 September 2008
Final FDA appro for Caraco's generic Metaglip
21 January 2008
Nordisk and Sciele sign marketing deal
26 November 2007
New liquid metformin launched by Rosemont
13 August 2007
Depomed and Esprit end ProQuin XR deal
16 July 2007
Final FDA OK for Mylan's generic of B-MS' Metaglip
23 April 2007
Strong data on Merck & Co's Janumet
18 December 2006
EC approves Takeda's antidiabetic Competact
14 August 2006
King Pharma and Depomed to co-promote Glumetza
3 July 2006
Andrx' 4th-qtr 2005 income drops 16%
27 March 2006
Biovail launches Glumetza in Canada
5 December 2005
FDA approves Takeda's ACTOplus met
5 September 2005
Depomed receives $25M from Biovail
18 July 2005
FDA clears Alpharma's Glucovance copy
11 July 2005
GSK's Paxil returns to US market
4 July 2005
Biovail/Depomed: FDA approves Glumetza
13 June 2005
Biovail/Depomed: FDA approves Glumetza
13 June 2005
FDA approves Biovail's Glumetza
14 March 2005
First Horizon buys two Andrx drugs for $85M
14 March 2005
SCOLR Pharma files provisional patent for rosiglitazone
10 January 2005
Ranbaxy launches Riomet, the first liquid metformin
1 March 2004
Tokyo pharma stocks - week to Jan 12
19 January 2004
Andrx and Takeda in diabetes deal
19 January 2004
Indian firms win US approvals, other news
6 October 2003
Andr submits Fortamet MA in EU
9 June 2003
B-MS extends range of Glucophage XR
21 April 2003
Merck KGaA seeks stand-alone marketing in Japan
17 March 2003
Caraco gets US OK for metformin/tramadol
4 February 2002
Stock Commentary New York
2 July 1998
E Merck Buys R-P'sStake In Lipha
16 January 1995
LIPHA'S GLUCOPHAGE
11 October 1993
Showing 1-47 of 47 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
